Article Cited by others

RESEARCH PAPER

Effect of addition of either sitagliptin or pioglitazone in patients with uncontrolled type 2 diabetes mellitus on metformin: A randomized controlled trial

Chawla Shalini, Kaushik Nitin, Singh Narinder Pal, Ghosh Raktim Kumar, Saxena Alpana

Year : 2013| Volume: 4| Issue : 1 | Page no: 27-32

   This article has been cited by
 
1 Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Infer
Fang Zhang, Lizhi Tang, Jing Li, Zhe Yan, Juan Li, Nanwei Tong
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021; Volume 14: 1243
[Pubmed]  [Google Scholar] [DOI]
2 COMPARATIVE STUDY OF SITAGLIPTINAND PIOGLITAZONE AS ADDONTHERAPY OVER PLASMA GLUCOSE LEVEL IN TYPE 2 DIABETES MELLITUS PATIENTS : AN OBSERVATIONAL COHORT STUDY
Ravindra Kumar Das, Rahul Kumar Sinha, Debarshi Jana
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. 2020; : 10
[Pubmed]  [Google Scholar] [DOI]
3 Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24?weeks
Sin Gon Kim, Kyoung Jin Kim, Kun Ho Yoon, Sung Wan Chun, Kyong Soo Park, Kyung Mook Choi, Soo Lim, Ji-Oh Mok, Hyoung Woo Lee, Ji A. Seo, Bong-Soo Cha, Mi Kyung Kim, Ho Sang Shon, Dong Seop Choi, Doo Man Kim
Diabetes, Obesity and Metabolism. 2020; 22(10): 1869
[Pubmed]  [Google Scholar] [DOI]
4 Enhancement of cognitive functions by rice bran extract in a neuroinflammatory mouse model via regulation of PPAR?
A.O. Mostafa,R.M. Abdel-Kader,O.A. Heikal
Journal of Functional Foods. 2018; 48: 314
[Pubmed]  [Google Scholar] [DOI]
5 Network meta-analysis of lorcaserin and oral hypoglycaemics for patients with type 2 diabetes mellitus and obesity
L. M. Neff,M. S. Broder,D. Beenhouwer,E. Chang,E. Papoyan,Z. W. Wang
Clinical Obesity. 2017;
[Pubmed]  [Google Scholar] [DOI]
6 Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis
Elena Filipova,Katya Uzunova,Krassimir Kalinov,Toni Vekov
Diabetology & Metabolic Syndrome. 2017; 9(1)
[Pubmed]  [Google Scholar] [DOI]
7 A PROSPECTIVE STUDY OF ADDITION OF SITAGLIPTIN TO METFORMIN VERSUS METFORMIN ALONE IN TYPE 2 DIABETES MELLITUS PATIENTS
Ramswaroop Jawaharlal, Pravin G. Maske
Journal of Evidence Based Medicine and Healthcare. 2017; 4(73): 4327
[Pubmed]  [Google Scholar] [DOI]
8 Pioglitazone utilization, efficacy & safety in Indian type 2 diabetic patients: A systematic review & comparison with European Medicines Agency Assessment Report
SarayuA Pai,NilimaA Kshirsagar
Indian Journal of Medical Research. 2016; 144(5): 672
[Pubmed]  [Google Scholar] [DOI]
9 Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)
Surjit Singh,Anil Bhansali
BMC Dermatology. 2016; 16(1)
[Pubmed]  [Google Scholar] [DOI]
10 Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins
Elena Pavlova Filipova,Katya Hristova Uzunova,Toni Yonkov Vekov
Diabetology & Metabolic Syndrome. 2015; 7(1)
[Pubmed]  [Google Scholar] [DOI]
11 Comparative Efficacy and Safety of Antidiabetic Drug Regimens Added to Metformin Monotherapy in Patients with Type 2 Diabetes: A Network Meta-Analysis
Elizabeth S. Mearns,Diana M. Sobieraj,C. Michael White,Whitney J. Saulsberry,Christine G. Kohn,Yunes Doleh,Eric Zaccaro,Craig I. Coleman,Wen-Chih Hank Wu
PLOS ONE. 2015; 10(4): e0125879
[Pubmed]  [Google Scholar] [DOI]
12 The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients
Nasser Aghamohammadzadeh,Mitra Niafar,Elham Dalir Abdolahinia,Farzad Najafipour,Saeed Mohamadzadeh Gharebaghi,Khadijeh Adabi,Elaheh Dalir Abdolahinia,Hamidreza Ahadi
Therapeutic Advances in Endocrinology and Metabolism. 2015; 6(2): 56
[Pubmed]  [Google Scholar] [DOI]
13 Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with Type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study
M. Bajaj,R. Gilman,S. Patel,J. Kempthorne-Rawson,D. Lewis-DęAgostino,H.-J. Woerle
Diabetic Medicine. 2014; 31(12): 1505
[Pubmed]  [Google Scholar] [DOI]

 

Read this article